Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces Leadership Transition

See Release

All News

Archives

Endologix to Present in Two Upcoming Healthcare Conferences.

Endologix Announces Results of Pooled Analysis of DETOUR1 and DETOUR2 Studies at 2023 VIVA Late-Breaking Clinical Trial Session

Endologix’s DETOURTM System Earns Spot in Local and National Award Forums; Nominated for Prix Galien USA’s Best Medical Technology

Endologix announces the U. S. Centers for Medicare & Medicaid Services granted a New Technology Add-on Payment for the DETOUR System

Endologix Announces that Lucas Buchanan Joins Board of Directors